健脾疏肝方对非酒精性脂肪性肝病模型大鼠PI3K/AKT/HIF-1α信号通路表达的影响OA
Effect of Jianpi Shugan Prescription on Expressions of PI3K/AKT/HIF-1α Signaling Pathway in Rats with Non-alcoholic Fatty Liver Disease
目的 研究健脾疏肝方对非酒精性脂肪性肝病(NAFLD)模型大鼠肝组织PI3K、AKT、mTOR、缺氧诱导因子(HIF)-1α、血管内皮生长因子A(VEGFA)表达的影响,探讨其调节NAFLD脂质代谢紊乱的作用机制.方法 60只SD大鼠随机分为对照组12只和高脂饮食组48只,分别予普通饲料和高脂饲料喂养8周构建NAFLD模型.模型复制成功后,将高脂饮食组大鼠随机分为模型组、辛伐他汀组和健脾疏肝方高、低剂量组,分别以相应药物灌胃6周.检测大鼠血脂及肝功能相关指标[总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)],HE染色观察肝组织形态,油红O染色观察肝组织脂质蓄积情况,ELISA检测肝组织脂质代谢酶甾醇调节元件结合蛋白(SREBP)-1c、脂肪酸合酶(FASN)、3-羟基3-甲基戊二酰辅酶A还原酶(HMGCR)、低密度脂蛋白受体(LDLR)含量,RT-PCR检测肝组织PI3K、AKT、mTOR、HIF-1α、VEGFA mRNA表达.结果 与对照组比较,模型组大鼠肝湿重、肝指数明显升高(P<0.01),血清TC、TG、LDL-C、ALT、AST及肝组织SREBP-1c、FASN、HMGCR含量明显升高(P<0.01),血清HDL-C和肝组织LDLR含量明显降低(P<0.01);肝组织出现明显脂肪变性,脂质蓄积增多,肝组织PI3K、AKT、mTOR、HIF-1α、VEGFA mRNA表达明显升高(P<0.01).与模型组比较,健脾疏肝方高剂量组、辛伐他汀组大鼠肝湿重、肝指数明显降低(P<0.05,P<0.01),血清TC、TG、LDL-C、ALT、AST及肝组织SREBP-1c、FASN、HMGCR含量明显降低,血清HDL-C和肝组织LDLR含量明显升高(P<0.05,P<0.01);肝组织脂肪变性减轻,脂质蓄积减少,肝组织PI3K、AKT、mTOR、HIF-1α、VEGFA mRNA表达明显降低(P<0.01).结论 健脾疏肝方可能通过抑制NAFLD模型大鼠PI3K/AKT/HIF-1α信号通路相关分子表达调控脂质代谢关键酶SREBP-1c、FASN、HMGCR、LDLR水平,改善脂质代谢紊乱,减轻肝脏脂质蓄积,发挥治疗NAFLD作用.
Objective To investigate the effects of Jianpi Shugan Prescription on the expressions of PI3K,AKT,mTOR,HIF-1α and VEGFA in liver tissue of non-alcoholic fatty liver disease(NAFLD)model rats;To explore the mechanism by which Jianpi Shugan Prescription regulates lipid metabolism disorder in NAFLD rats.Methods A total of 60 SD rats were randomly divided into control group(12 rats)and high-fat diet group(48 rats),which were respectively fed with a normal diet and a high-fat diet for 8 weeks to establish the NAFLD model.After the model was successfully established,the rats in the high-fat diet group were randomly assigned into model group,simvastatin group and Jianpi Shugan Prescription high-and low-dosage groups.Each group was administered the corresponding drugs via gavage for 6 weeks.The contents of serum lipid-related indexes and liver function-related indexes(TC,TG,HDL-C,LDL-C,ALT and AST)were determined,HE staining was employed to observe the morphology of liver tissue,and oil red O staining was utilized to observe the liver lipid accumulation,the contents of liver lipid metabolism enzymes of SREBP-1c,FASN,HMGCR and LDLR were measured by ELISA,the mRNA expressions of PI3K,AKT,mTOR,HIF-1α and VEGFA in liver tissue were detected by RT-PCR.Results Compared with the control group,the liver wet weight and liver index of the model group significantly increased(P<0.01),the contents of serum TC,TG,LDL-C,ALT,AST and SREBP-1c,FASN,HMGCR in liver tissue significantly increased(P<0.01),and the contents of serum HDL-C and LDLR in liver tissue significantly decreased(P<0.01);the liver presented obvious steatosis and increased lipid accumulation;the mRNA expression of PI3K,AKT,mTOR,HIF-1α and VEGFA in liver tissue significantly increased(P<0.01).Compared with the model group,the liver wet weight and liver index of rats in Jianpi Shugan Prescription high-dosage group and simvastatin group significantly decreased(P<0.05,P<0.01),and the contents of serum TC,TG,LDL-C,ALT,AST and SREBP-1c,FASN,HMGCR in liver tissue significantly decreased,while the contents of serum HDL-C and LDLR in liver tissue significantly increased(P<0.05,P<0.01);the degree of liver steatosis and lipid accumulation was alleviated;the mRNA expressions of PI3K,AKT,mTOR,HIF-1α and VEGFA in liver tissue were significantly increased(P<0.01).Conclusion Jianpi Shugan Prescription may regulate the levels of SREBP-1c,FASN,HMGCR,LDLR,improve lipid metabolism disorder,reduce liver lipid accumulation,and play a role in the treatment of NAFLD by inhibiting the expressions of PI3K/AKT/HIF-1α signaling pathway related molecules in NAFLD model rats.
王晓雨;李冀;付强;付殷;韩东卫;胡晓阳
黑龙江中医药大学,黑龙江 哈尔滨 150040黑龙江中医药大学,黑龙江 哈尔滨 150040黑龙江中医药大学,黑龙江 哈尔滨 150040黑龙江中医药大学,黑龙江 哈尔滨 150040黑龙江中医药大学,黑龙江 哈尔滨 150040黑龙江中医药大学,黑龙江 哈尔滨 150040
医药卫生
健脾疏肝方非酒精性脂肪性肝病脂肪酸合成PI3K/AKT/HIF-1α信号通路大鼠
Jianpi Shugan PrescriptionNAFLDfatty acid synthesisPI3K/AKT/HIF-1α signaling pathwayrats
《中国中医药信息杂志》 2026 (1)
84-90,7
黑龙江省自然科学基金(YQ2021H026)黑龙江省青年中医药科研项目(ZHY2025-287)中医药传承与创新"百千万"人才工程(岐黄工程)岐黄学者项目(2018年)
评论